These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9645195)
1. Slight difference in primary amino acid sequence of p17 matrix protein of HIV-1 exerts profound influence on its antigenicity. Taniguchi K; Tsuchie H; Kageyama S; Iwasaki M; Takagi T; Sasao F; Ueda S; Kurimura T Arch Virol; 1998; 143(5):881-90. PubMed ID: 9645195 [TBL] [Abstract][Full Text] [Related]
2. Three antigenic regions in p17 of human immunodeficiency virus type 1 (HIV-1) revealed by mouse monoclonal antibodies and human antibodies in HIV-1 carrier sera. Liu X; Ota A; Watanabe M; Ueda S; Saitoh A; Shinagawa H; Nakata A; Kurimura T; Wang X; Zhao Y Microbiol Immunol; 1995; 39(10):775-85. PubMed ID: 8577268 [TBL] [Abstract][Full Text] [Related]
3. Gag-derived proteins of HIV-1 isolates from Indian patients: cloning, expression, and purification of p17 of B- and C-subtypes. Gupta S; Arora K; Gupta A; Chaudhary VK Protein Expr Purif; 2001 Apr; 21(3):378-85. PubMed ID: 11281711 [TBL] [Abstract][Full Text] [Related]
4. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH. Fiorentini S; Marini E; Bozzo L; Trainini L; Saadoune L; Avolio M; Pontillo A; Bonfanti C; Sarmientos P; Caruso A Biopolymers; 2004; 76(4):334-43. PubMed ID: 15386266 [TBL] [Abstract][Full Text] [Related]
5. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins. Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866 [TBL] [Abstract][Full Text] [Related]
6. Coexisting members of HIV-1 p17 gene quasispecies represent proteins with distinct antigenicity and immunogenicity. Birk M; Flock JI; Sönnerborg A; Sällberg M AIDS; 1998 Oct; 12(15):1973-81. PubMed ID: 9814865 [TBL] [Abstract][Full Text] [Related]
7. Immunodominant epitopes of HIV-1 p17 and p24. Graham S; Follett EA; Wallace L; Desselberger U; Marsden HS AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1781-8. PubMed ID: 1280955 [TBL] [Abstract][Full Text] [Related]
8. Characterization of mother-infant HIV type 1 gag p17 sequences associated with perinatal transmission. Hahn T; Matala E; Chappey C; Ahmad N AIDS Res Hum Retroviruses; 1999 Jul; 15(10):875-88. PubMed ID: 10408724 [TBL] [Abstract][Full Text] [Related]
9. Production and characterization of a mouse monoclonal antibody against the Gag p26 protein of human immunodeficiency virus type 2: identification of a new antigenic epitope. Marcelino JM; Novo C; Pereira JM; Picotez F; Clemente A; Taveira N AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1279-83. PubMed ID: 11559428 [TBL] [Abstract][Full Text] [Related]
10. Nonsynonymous mutations within the human immunodeficiency virus type 1 p17 gene are clustered to sequences binding to the host human leukocyte antigen class I molecules. Birk M; Vahlne A; Sönnerborg A; Sällberg M AIDS Res Hum Retroviruses; 1998 Feb; 14(3):241-8. PubMed ID: 9491914 [TBL] [Abstract][Full Text] [Related]
11. Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells. Shang F; Huang H; Revesz K; Chen HC; Herz R; Pinter A J Virol; 1991 Sep; 65(9):4798-804. PubMed ID: 1714518 [TBL] [Abstract][Full Text] [Related]
12. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide. Ota A; Tanaka-Taya K; Ueda S Hybridoma; 1999 Apr; 18(2):149-57. PubMed ID: 10380014 [TBL] [Abstract][Full Text] [Related]
13. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442 [TBL] [Abstract][Full Text] [Related]
14. A unique monoclonal antibody that recognizes mature p17 of HIV-1 but not its precursor. Saitoh A; Tanaka N; Nakata A; Ikuta K; Shinagawa H Microbiol Immunol; 1992; 36(1):105-11. PubMed ID: 1584067 [TBL] [Abstract][Full Text] [Related]
15. Characterization of murine monoclonal antibodies directed against the submembrane protein p17 of HIV-1. Niedrig M; Harthus HP; Bröker M; Meloen R; Gelderblom H; Pauli G Hybridoma; 1993 Aug; 12(4):431-9. PubMed ID: 7503941 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory mechanism of anti-P30-52 monoclonal antibody against human immunodeficiency virus type 1 (HIV-1) multiplication in infected MT-4 cells. Ota A; Ueda S Hybridoma; 1999 Jun; 18(3):235-41. PubMed ID: 10475237 [TBL] [Abstract][Full Text] [Related]
17. Epitope mapping of the HIV-1 gag region with monoclonal antibodies. Hinkula J; Rosen J; Sundqvist VA; Stigbrand T; Wahren B Mol Immunol; 1990 May; 27(5):395-403. PubMed ID: 1694957 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to the HIV-1 p17 protein cross-react with human superoxide dismutase-2. Kato T; Suzuki J; Daimon M; Sasaki H; Ishikawa K Biochem Biophys Res Commun; 1997 Jan; 230(1):184-7. PubMed ID: 9020042 [TBL] [Abstract][Full Text] [Related]
19. Pairwise decomposition of residue interaction energies of single chain Fv with HIV-1 p17 epitope variants. Lee VS; Tue-ngeun P; Nangola S; Kitidee K; Jitonnom J; Nimmanpipug P; Jiranusornkul S; Tayapiwatana C Mol Immunol; 2010 Feb; 47(5):982-90. PubMed ID: 20022377 [TBL] [Abstract][Full Text] [Related]
20. Random expression of human immunodeficiency virus-1 (HIV-1) p17 (epitopes) on the surface of the HIV-1-infected cell. Ota A; Liu X; Fujio H; Sakato N; Ueda S Hybridoma; 1998 Feb; 17(1):73-5. PubMed ID: 9523241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]